A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides

作者: Takahiko Matsushita , Wataru Takada , Kota Igarashi , Kentaro Naruchi , Risho Miyoshi

DOI: 10.1016/J.BBAGEN.2013.11.009

关键词:

摘要: Human serum MUC1 peptide fragments bearing aberrant O-glycans are secreted from columnar epithelial cell surfaces and known as clinically important biomarkers for the carcinoma when a specific monoclonal antibody can probe disease-relevant epitopes. Despite growing importance of glycopeptides biomarkers, precise epitopes most anti-MUC1 antibodies remains unclear.A novel protocol fabrication versatile microarray displaying peptide/glycopeptide library was investigated construction highly sensitive accurate epitope mapping assay various antibodies.Selective imine-coupling between aminooxy-functionalized methacrylic copolymer with phosphorylcholine unit synthetic glycopeptides-capped by ketone linker at N-terminus provided facile seamless preparation platform. It demonstrated that anti-KL-6 shows an extremely strong binding affinity toward carrying sialyl T antigen (Neu5Acα2,3Galβ1,3GalNAcα1→) Pro-Asp-Thr-Arg motif compared other seven such VU-3D1, VU-12E1, VU-11E2, Ma552, VU-3C6, SM3, DF3. The present also uncovered occurrence IgG autoantibodies in healthy human sera bind specifically attached five potential O-glycosylation sites tandem repeats.We established straightforward strategy standardized platform allowing analysis reducing background noise due to nonspecific protein adsorption.The approach would greatly accelerate discovery research new class well development therapeutic mAbs reacting

参考文章(99)
Pinku Mukherjee, Amelia R. Ginardi, Cathy S. Madsen, Teresa L. Tinder, Fred Jacobs, Joanne Parker, Babita Agrawal, B. Michael Longenecker, Sandra J. Gendler, MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. Glycoconjugate Journal. ,vol. 18, pp. 931- 942 ,(2001) , 10.1023/A:1022260711583
Udo Jeschke, Tobias Weissenbacher, Miriam Lenhard, Sabine Heublein, Uwe Karsten, Steffen Goletz, Doris Mayr, Darius Dian, Klaus Friese, Christina Kuhn, Irmi Wiest, Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8. Histology and Histopathology. ,vol. 28, pp. 239- 244 ,(2013) , 10.14670/HH-28.239
Shin-Ichiro Nishimura, Toward automated glycan analysis. Advances in Carbohydrate Chemistry and Biochemistry. ,vol. 65, pp. 219- 271 ,(2011) , 10.1016/B978-0-12-385520-6.00005-4
Lucien Perey, Daniel F Hayes, Peter Maimonis, Miyako Abe, Carl O'Hara, Donald W Kufe, None, Tumor Selective Reactivity of a Monoclonal Antibody Prepared against a Recombinant Peptide Derived from the DF3 Human Breast Carcinoma-associated Antigen Cancer Research. ,vol. 52, pp. 2563- 2568 ,(1992)
Kazumi Hiruma-Shimizu, Kensaku Hosoguchi, Yan Liu, Naoki Fujitani, Takashi Ohta, Hiroshi Hinou, Takahiko Matsushita, Hiroki Shimizu, Ten Feizi, Shin-Ichiro Nishimura, Chemical Synthesis, Folding, and Structural Insights into O-Fucosylated Epidermal Growth Factor-like Repeat 12 of Mouse Notch-1 Receptor Journal of the American Chemical Society. ,vol. 132, pp. 14857- 14865 ,(2010) , 10.1021/JA105216U
Richard M. Tempero, Michelle L. VanLith, Gerald J. Rowse, Sandra J. Gendler, Michael A. Hollingsworth, Tolerance and Immunity to MUC1 in a Human MUC1 Transgenic Murine Model Cancer Research. ,vol. 58, pp. 315- 321 ,(1998)
Hwee Tong Tan, Jiayi Low, Seng Gee Lim, Maxey C. M. Chung, Serum autoantibodies as biomarkers for early cancer detection. FEBS Journal. ,vol. 276, pp. 6880- 6904 ,(2009) , 10.1111/J.1742-4658.2009.07396.X
Gunther Klich, Uwe Karsten, Steffen Goletz, Hans Paulsen, Stefan Müller, Franz-Georg Hanisch, Catherine Diotel, Enhanced Binding of Antibodies to the DTR Motif of MUC1 Tandem Repeat Peptide Is Mediated by Site-specific Glycosylation Cancer Research. ,vol. 58, pp. 2541- 2549 ,(1998)
P. F. Bruning, V. Kroezen, J. Hilkens, J. M. G. Bonfrer, M. De Jong-Bakker, MAM-6 Antigen, a New Serum Marker for Breast Cancer Monitoring Cancer Research. ,vol. 46, pp. 2582- 2587 ,(1986)